Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A. Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Blood (2007) Vol. 110, Iss. 3, pp. 1022-1024
Open Access | Times Cited: 158

Showing 26-50 of 158 citing articles:

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells
Romain Gioia, Cédric Leroy, Claire Drullion, et al.
Blood (2011) Vol. 118, Iss. 8, pp. 2211-2221
Open Access | Times Cited: 100
The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents
Cédric Dos Santos, Tinisha McDonald, Yin Wei Ho, et al.
Blood (2013) Vol. 122, Iss. 11, pp. 1900-1913
Open Access | Times Cited: 98
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML
Lars Bullinger, Konstanze Döhner, Raphael Kranz, et al.
Blood (2008) Vol. 111, Iss. 9, pp. 4490-4495
Open Access | Times Cited: 98
Drug resistance in mutant FLT3-positive AML
Ellen Weisberg, Martin Sattler, Arghya Ray, et al.
Oncogene (2010) Vol. 29, Iss. 37, pp. 5120-5134
Closed Access | Times Cited: 94
Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases
Jasmine V. Abella, Morag Park
AJP Endocrinology and Metabolism (2009) Vol. 296, Iss. 5, pp. E973-E984
Closed Access | Times Cited: 93
Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling
Chozhavendan Rathinam, Christine B.F. Thien, Richard A. Flavell, et al.
Cancer Cell (2010) Vol. 18, Iss. 4, pp. 341-352
Closed Access | Times Cited: 93
A Restricted Spectrum of Mutations in the SMAD4 Tumor-Suppressor Gene Underlies Myhre Syndrome
Viviana Caputo, L Cianetti, Marcello Niceta, et al.
The American Journal of Human Genetics (2012) Vol. 90, Iss. 1, pp. 161-169
Open Access | Times Cited: 92
Genetic predispositions to childhood leukemia
Elliot Stieglitz, Mignon L. Loh
Therapeutic Advances in Hematology (2013) Vol. 4, Iss. 4, pp. 270-290
Open Access | Times Cited: 87
Modulation of Immune Cell Functions by the E3 Ligase Cbl-b
Christina Lutz‐Nicoladoni, Dominik Wolf‎, Sieghart Sopper
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 82
Genetic and epigenetic alterations of myeloproliferative disorders
Jelena D. Milosevic Feenstra, Róbert Královics
International Journal of Hematology (2012) Vol. 97, Iss. 2, pp. 183-197
Open Access | Times Cited: 77
EGFR Trafficking in Physiology and Cancer
Giusi Caldieri, Maria Grazia Malabarba, Pier Paolo Di Fiore, et al.
Progress in molecular and subcellular biology (2018), pp. 235-272
Closed Access | Times Cited: 71
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia
Rina Nishii, Rebekah Baskin-Doerfler, Wentao Yang, et al.
Blood (2020) Vol. 137, Iss. 3, pp. 364-373
Open Access | Times Cited: 55
Prognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal Cytogenetics
Verena I. Gaidzik, Konstanze Döhner
Seminars in Oncology (2008) Vol. 35, Iss. 4, pp. 346-355
Closed Access | Times Cited: 95
Ubiquitination and degradation of the thrombopoietin receptor c-Mpl
Sebastian Saur, Veena Sangkhae, Amy E. Geddis, et al.
Blood (2009) Vol. 115, Iss. 6, pp. 1254-1263
Open Access | Times Cited: 91
As 4 S 4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia
Jianhua Mao, Xiaoyan Sun, Jianxiang Liu, et al.
Proceedings of the National Academy of Sciences (2010) Vol. 107, Iss. 50, pp. 21683-21688
Open Access | Times Cited: 86
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies
Ulrike Bacher, Claudia Haferlach, Susanne Schnittger, et al.
Annals of Hematology (2010) Vol. 89, Iss. 7, pp. 643-652
Open Access | Times Cited: 70
Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing
Winnie S. Liang, David W. Craig, John D. Carpten, et al.
PLoS ONE (2012) Vol. 7, Iss. 10, pp. e43192-e43192
Open Access | Times Cited: 70
Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia
Ulrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
British Journal of Haematology (2011) Vol. 153, Iss. 2, pp. 149-167
Open Access | Times Cited: 61
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies
Kaosheng Lv, Jing Jiang, Ryan Donaghy, et al.
Genes & Development (2017) Vol. 31, Iss. 10, pp. 1007-1023
Open Access | Times Cited: 56
JAK2V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms
Stephen T. Oh, Jason Gotlib
Expert Review of Hematology (2010) Vol. 3, Iss. 3, pp. 323-337
Closed Access | Times Cited: 65
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl
Christopher Slape, Leah Y. Liu, Sarah H. Beachy, et al.
Blood (2008) Vol. 112, Iss. 5, pp. 2017-2019
Open Access | Times Cited: 63
Myeloproliferative neoplasms: Current molecular biology and genetics
Kolsoum Saeidi
Critical Reviews in Oncology/Hematology (2015) Vol. 98, pp. 375-389
Closed Access | Times Cited: 48
Molecular Diversity and Associated Phenotypic Spectrum of GermlineCBLMutations
Simone Martinelli, Emilia Stellacci, Luca Pannone, et al.
Human Mutation (2015) Vol. 36, Iss. 8, pp. 787-796
Closed Access | Times Cited: 44
Chapter Six - The Ubiquitin Network in the Control of EGFR Endocytosis and Signaling
Alexia Conte, Sara Sigismund
Progress in molecular biology and translational science (2016), pp. 225-276
Closed Access | Times Cited: 41
CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1
Roger Belizaire, Sebastian Koochaki, Namrata D. Udeshi, et al.
Blood (2021) Vol. 137, Iss. 16, pp. 2209-2220
Open Access | Times Cited: 30

Scroll to top